SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Mallinckrodt Completes Rolling Submission Of New Drug Application To FDA Terlipressin ForTreatment Of Patients With Hepatorenal Syndrome Type 1 (HRS-1)

Benzinga · 03/17/2020 10:50